Earnings Scheduled For February 6, 2024
Companies Reporting Before The Bell
• BP (NYSE:BP) is projected to report quarterly earnings at $1.05 per share on revenue of $53.50 billion.
Earnings Outlook For Deciphera Pharmaceuticals
Deciphera Pharmaceuticals (NASDAQ:DCPH) is set to give its latest quarterly earnings report on Tuesday, 2024-02-06. Here’s what investors…
Deciphera Pharmaceuticals Results Of INTRIGUE Study Long-Term Follow-Up, In The Primary Analysis Of The AP-ITT Population Based On A Data Cut Of September 1, 2021, The Primary Endpoint Was Not achieved
Results of INTRIGUE Study Long-Term Follow-UpIn INTRIGUE, 453 patients in the all-patient intent-to-treat population (AP-ITT) with second-line GIST were randomized 1:1 to receive QINLOCK 150 mg once daily (n=226) or
Deciphera Pharmaceuticals Presents Long-Term Follow-Up Results From INTRIGUE Phase 3 Clinical Study In Second-Line GIST Patients At The 2024 American Society Of Clinical Oncology Gastrointestinal Cancers Symposium
– Median Overall Survival for QINLOCK® of 35.5 Months Versus 31.5 Months for Sunitinib in the All-Patient Intent-to Treat-Population –– Long-Term Safety Profile Consistent with Primary Analysis Showing Fewer
What 4 Analyst Ratings Have To Say About Deciphera Pharmaceuticals
Within the last quarter, Deciphera Pharmaceuticals (NASDAQ:DCPH) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…
Deciphera Pharmaceuticals’ Investigational Drug Shows Encouraging Response Rates In Rare Type Of Cancer
Deciphera Pharmaceuticals Inc (NASDAQ: DCPH) announced top-line results from the MOTION Phase 3 study of vimseltinib in patients with Tenosynovial Giant Cell Tumor (TGCT)
Western Digital, JinkoSolar, Lumentum Holdings And Other Big Stocks Moving Higher On Monday
U.S. stocks traded higher, with the Nasdaq Composite gaining more than 100 points on Monday. Here are some big stocks recording gains in today’s session.
Stocks That Hit 52-Week Lows On Thursday
During Thursday's session, 406 companies made new 52-week lows.